Niall Cairns, BEc., ACA, FAICD


Niall Cairns joined CardieX in 2017. As a Sydney-based technology growth investor, Mr. Cairns has a 25-year track record of value creation, restructuring, and exits in both listed and unlisted companies, having assisted in driving the global growth of over 50 companies in sectors as diverse as digital media, agtech, medtech, consumer Internet, and SaaS based businesses. He is currently the Chairman of Tambla Limited, a Non-Executive Director of Chant West Holdings and Tru-Test Limited, Co-Owner of C2 Ventures Pty Ltd., as well as Kestrel Capital and the Carnethy Group of companies. Mr Cairns is also a Principal of C2 Ventures Pty Ltd, CardieX's largest shareholder.

Craig R. Cooper, BEc., LLB (Hons)

Executive Director, Chief Executive Officer & Managing Director

Craig Cooper joined CardieX in 2017. A serial entrepreneur, venture capitalist, author, and CNBC business network TV host, Mr. Cooper was previously the co-founder of Boost Mobile (USA), the Managing Director and Head of Venture Capital at Saban Ventures, a founding Partner in the Softbank Capital Technology Fund, co-founder of NRG Asia–Pacific (Australia's largest private electricity supplier), and a founding director of EBT Mobile - China's largest private mobile phone retailer. He was also a Senior Associate at Australia’s largest national law firm where he acted for clients such as United Airlines, The Disney Corporation, and DHL International (where he was External General Counsel). Mr. Cooper has a Bachelor of Economics and a Bachelor of Laws (Honors) from the University of Sydney in Australia. Mr Cooper is also a Principal of C2 Ventures Pty Ltd, CardieX's largest shareholder.

R. King Nelson, BA, MBA

Non-Executive Director

King was elected to the Board in November 2015. He brings more than 30 years of diverse experience and expertise with medical devices. He was previously President and CEO of Uptake Medical Corporation, a company focused on treatments for emphysema and lung cancer. Prior to to that, he served as president and CEO of Kerberos Proximal Solutions, which was acquired by FoxHollow Technologies, and as president and CEO of VenPro, a heart valve business acquired by Medtronic. Both these companies specialized in devices for the cardiovascular system. Prior to that, he spent 19 years with Baxter International and American Hospital Supply Corporation in roles of increasing responsibility that included division president for Dade Diagnostics, Bentley Labs, and Baxter’s Perfusion Services.


Craig R. Cooper

CEO & Managing Director

See Board of Directors (above)

Jarrod White

Chief Financial Officer

Traverse Accountants
University of Sydney

Alberto Avolio


Professor of Biomedical Engineering
The Australian School of Advanced Medicine, Macquarie University

Doug Kurschinski

EVP & Head of Global Sales

Cardiac Pathways (Boston Scientific)
St Jude Medical (Abbott)

ZiHan Lin

VP of Corporate Development

Uptake Medical
Harvard / Stanford

Chris Dax

President of ATCOR. VP of Operations - CardieX

ISTA Pharmaceuticals
Elan Pharmaceuticals

Rhonda Welch

VP of Health Economics

Welch Healthcare Consulting
Biosense Webster, J&J
Baxter Healthcare

Antony Sloan

Global Head of Marketing & Communications

Avery Dennison

Lawrence Chan

Director of Product Development

Silverbrook Research

Ahmad Qasem

Principal Scientist

PhD in Biomedical Engineering
Macquarie University

Ric Ruffhead

Director of Sales

EP MedSystems (St. Jude)
Cardiac Pathways (Boston Scientific)

Bobby Stutz

Director, Pharmaceutical Markets & Scientific Affairs

MBE in Biomedical Engineering
The Catholic University of America

Qian Wang

Business Development (China)

New NI Medical
Haishu Medical

Shunyao Li

Operations (China)

12 Sigma